Sacituzumab tirumotecan for treating advanced or metastatic gastric, gastro-oesophageal junction or oesophageal adenocarcinoma after 2 or more treatment lines [ID6723]

• Awaiting development
• Reference number: GID-TA11932
• Expected publication date: TBC